Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 2TP53 Y220C Mutation 1Smoking 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Peripheral Nervous System Diseases 1Meningioma 1Medulloblastoma 1Lymphoma, Mantle-Cell 1Localized Prostate Cancer 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1HER2 IHC3+ Advanced Colorectal Cancer 1Genetic Diseases, Inborn 1Deglutition Disorders 1Cognitive Dysfunction 1

Interventions

mazdutide 1lime 1fasudil 1Tablets 1Referral and Consultation 1Ramipril 1Radiosurgery 1Metformin 1Mental Status and Dementia Tests 1Memantine 1Health 1Exercise 1Acetylcysteine 1Accidental Falls 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Tablets × 90 days × Clear all
NCT05230758 2026-05-01

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting
140 enrolled
CNS

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡